HHV-6 associated diseases are one of the major factors on higher early CNS complications in CB recipients than in those of BM/PBSC

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Kishi Y, Miyakoshi S, Kami M, Ikeda M, Katayama Y, Murashige N, et al. Early central nervous system complications after reduced-intensity stem cell transplantation. Biol Blood Marrow Transpl. 2004;10:561–8. https://doi.org/10.1016/j.bbmt.2004.05.004.

    Article  Google Scholar 

  2. 2.

    Hill JA, Koo S, Guzman Suarez BB, Ho VT, Cutler C, Koreth J, et al. Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis. Biol Blood Marrow Transpl. 2012;18:1638–48. https://doi.org/10.1016/j.bbmt.2012.04.016.

    Article  Google Scholar 

  3. 3.

    Siegal D, Keller A, Xu W, Bhuta S, Kim DH, Kuruvilla J, et al. Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. Biol Blood Marrow Transpl. 2007;13:1369–79. https://doi.org/10.1016/j.bbmt.2007.07.013.

    Article  Google Scholar 

  4. 4.

    Kang JM, Kim YJ, Kim JY, Cho EJ, Lee JH, Lee MH, et al. Neurologic complications after allogeneic hematopoietic stem cell transplantation in children: analysis of prognostic factors. Biol Blood Marrow Transpl. 2015;21:1091–8. https://doi.org/10.1016/j.bbmt.2015.02.007.

    Article  Google Scholar 

  5. 5.

    Schultze-Florey CR, Peczynski C, de Marino I, Polge E, Socie G, Blaise D, et al. Frequency of lethal central nervous system neurotoxicity in patients undergoing allogeneic stem cell transplantation: a retrospective registry analysis. Bone Marrow Transpl. 2019. https://doi.org/10.1038/s41409-019-0738-3.

  6. 6.

    Ogata M, Oshima K, Ikebe T, Takano K, Kanamori H, Kondo T, et al. Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 2017;52:1563–70. https://doi.org/10.1038/bmt.2017.175.

    CAS  Article  Google Scholar 

  7. 7.

    Hakko E, Ozkan HA, Karaman K, Gulbas Z. Analysis of cerebral toxoplasmosis in a series of 170 allogeneic hematopoietic stem cell transplant patients. Transpl Infect Dis. 2013;15:575–80. https://doi.org/10.1111/tid.12138.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Zerr DM, Gupta D, Huang ML, Carter R, Corey L. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34:309–17. https://doi.org/10.1086/338044.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Mori Y, Miyamoto T, Nagafuji K, Kamezaki K, Yamamoto A, Saito N, et al. High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation. Biol Blood Marrow Transpl. 2010;16:1596–602. https://doi.org/10.1016/j.bbmt.2010.05.009.

    Article  Google Scholar 

  10. 10.

    Asano-Mori Y, Ishiwata K, Ikebe T, Ota H, Nishida A, Tsuji M, et al. Prophylactic foscarnet and suppression of pre-engraftment immune reaciton are essential to overcome the development of HHV-6 encephalitis: from the experience of 496 adult cord blood transplants in Toranomon Hospital. Blood 2012;120: (abstract 461). 

  11. 11.

    Dowling MR, Li S, Dey BR, McAfee SL, Hock HR, Spitzer TR, et al. Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact. Bone Marrow Transpl. 2018;53:199–206. https://doi.org/10.1038/bmt.2017.239.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Naoyuki Uchida.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kageyama, K., Uchida, N., Yamamoto, H. et al. HHV-6 associated diseases are one of the major factors on higher early CNS complications in CB recipients than in those of BM/PBSC. Bone Marrow Transplant (2020). https://doi.org/10.1038/s41409-020-01028-5

Download citation

Search